UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Perceived barriers and facilitators of using dietary modification for CKD prevention among African Americans of low socioeconomic status: a qualitative study

BMC nephrology, 2014-12, Vol.15 (1), p.194-194, Article 194

2014

Volltextzugriff (PDF)

Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations

Journal of the American Society of Nephrology, 2001-05, Vol.12 (5), p.1059-1071

2001

Volltextzugriff (PDF)

Variation in Weight Loss Goals of U.S. Adults Meeting BMI Criteria for Anti-Obesity Pharmacotherapy

Obesity (Silver Spring, Md.), 2023-11, Vol.31, p.165-165

2023

Volltextzugriff (PDF)

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR + , HER2 - breast cancer that had progressed during or after prior endocrine therapy

Breast cancer research : BCR, 2017-02, Vol.19 (1), p.18-18, Article 18

2017

Volltextzugriff (PDF)

Weight-Reduction Preferences Among OBSERVE Study Participants With Obesity or Overweight: Opportunities for Shared Decision-Making

Endocrine practice, 2024-10, Vol.30 (10), p.917-926

2024

Volltextzugriff (PDF)

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

Transplantation, 1998-10, Vol.66 (8), p.1040

1998

Volltextzugriff (PDF)

Awareness, Care and Treatment In Obesity maNagement to inform Haemophilia Obesity Patient Empowerment (ACTION‐TO‐HOPE): Results of a survey of US haemophilia treatment centre professionals

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-01, Vol.26 (S1), p.20-30

2020

Volltextzugriff (PDF)

The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent

Clinical pharmacology and therapeutics, 1998-01, Vol.63 (1), p.48-53

1998

Volltextzugriff (PDF)

Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection

Clinical chemistry (Baltimore, Md.), 1996-12, Vol.42 (12), p.1943-1948

1996

Volltextzugriff (PDF)

Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray- mass spectrometry

Clinical chemistry (Baltimore, Md.), 1996-09, Vol.42 (9), p.1417-1425

1996

Volltextzugriff (PDF)

Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat : Evidence for pharmacokinetic interactions

Therapeutic drug monitoring, 1998-04, Vol.20 (2), p.123-133

1998

Volltextzugriff (PDF)

Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats

Transplantation, 1996-10, Vol.62 (7), p.986

1996

Volltextzugriff (PDF)

Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipients

Biopharmaceutics & drug disposition, 1999-07, Vol.20 (5), p.249-253

1999

Volltextzugriff (PDF)

Consensus guidelines for therapeutic drug monitoring of rapamycin : report of the consensus panel

Therapeutic drug monitoring, 1995-12, Vol.17 (6), p.676-680

1995

Volltextzugriff (PDF)

A limited sampling strategy for estimating sirolimus area-under-the-concentration curve

Clinical chemistry (Baltimore, Md.), 1997-03, Vol.43 (3), p.539-540

1997

Volltextzugriff (PDF)

Distribution of sirolimus in rat tissue

Clinical biochemistry, 1997-03, Vol.30 (2), p.135-142

1997

Volltextzugriff (PDF)

Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1

Transplantation, 2001-06, Vol.71 (11), p.1585-1592

2001

Volltextzugriff (PDF)

Comparison of steady-state trough sirolimus samples by HPLC and a radioreceptor assay

Clinical biochemistry, 2000-02, Vol.33 (1), p.31-36

2000

Volltextzugriff (PDF)

Correlation between pretransplantation test dose cyclosporine pharmacokinetic profiles and posttransplantation sirolimus blood levels in renal transplant recipients

Therapeutic drug monitoring, 1999-02, Vol.21 (1), p.44-49

1999

Volltextzugriff (PDF)

COMPARISON OF THE PHARMACOKINETICS OF SIROLIMUS (RAPAMUNE®) IN RENAL TRANSPLANT RECIPIENTS FOLLOWING ADMINISTRATION OF THE LIQUID OR SOLID TABLET FORMULATIONS: Abstract# 158 Poster Board #-Session: P5-I

Transplantation, 2000-04, Vol.69 (Supplement), p.S154

2000

Volltextzugriff (PDF)

Generation of oxygen free radicals during the metabolism of cyclosporine A : a cause-effect relationship with metabolism inhibition

Molecular and cellular biochemistry, 1993-05, Vol.122 (2), p.101-112

1993

Volltextzugriff (PDF)

High-performance liquid chromatography of rapamycin

Clinical chemistry (Baltimore, Md.), 1991-02, Vol.37 (2), p.294-295

1991

Volltextzugriff (PDF)

IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1

Transplantation, 1998-10, Vol.66 (8), p.1040-1046

1998

Volltextzugriff (PDF)

Radioreceptor Assay for Sirolimus in Patients with Decreased Platelet Counts

Clinical biochemistry, 1997-10, Vol.30 (7), p.539-543

1997

Volltextzugriff (PDF)

Radioreceptor assay for sirolimus

Clinical biochemistry, 1996-10, Vol.29 (5), p.457-460

1996

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Biological And Medical Sciences
(18)
Medical Sciences
(17)
Pharmacology. Drug Treatments
(17)
Humans
(16)
Sirolimus
(15)
Medical Laboratory Technology
(12)
Immunomodulators
(11)
Animals
(10)
Immunosuppressive Agents - Blood
(10)
Male
(10)
Kidney Transplantation
(9)
Immunosuppressive Agents - Administration & Dosage
(8)
Adult
(7)
Immunosuppressive Agents - Pharmacokinetics
(7)
Polyenes - Blood
(7)
Rats
(7)
Cyclosporine - Administration & Dosage
(6)
Cyclosporine - Pharmacokinetics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Perceived barriers and facilitators of using dietary modification for CKD prevention among African Americans of low socioeconomic status: a qualitative study

Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations

Variation in Weight Loss Goals of U.S. Adults Meeting BMI Criteria for Anti-Obesity Pharmacotherapy

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR + , HER2 - breast cancer that had progressed during or after prior endocrine therapy

Weight-Reduction Preferences Among OBSERVE Study Participants With Obesity or Overweight: Opportunities for Shared Decision-Making

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

Awareness, Care and Treatment In Obesity maNagement to inform Haemophilia Obesity Patient Empowerment (ACTION‐TO‐HOPE): Results of a survey of US haemophilia treatment centre professionals

The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent

Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection

Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray- mass spectrometry

Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat : Evidence for pharmacokinetic interactions

Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats

Conversion from liquid to solid rapamycin formulations in stable renal allograft transplant recipients

Consensus guidelines for therapeutic drug monitoring of rapamycin : report of the consensus panel

A limited sampling strategy for estimating sirolimus area-under-the-concentration curve

Distribution of sirolimus in rat tissue

Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1

Comparison of steady-state trough sirolimus samples by HPLC and a radioreceptor assay

Correlation between pretransplantation test dose cyclosporine pharmacokinetic profiles and posttransplantation sirolimus blood levels in renal transplant recipients

COMPARISON OF THE PHARMACOKINETICS OF SIROLIMUS (RAPAMUNE®) IN RENAL TRANSPLANT RECIPIENTS FOLLOWING ADMINISTRATION OF THE LIQUID OR SOLID TABLET FORMULATIONS: Abstract# 158 Poster Board #-Session: P5-I

Generation of oxygen free radicals during the metabolism of cyclosporine A : a cause-effect relationship with metabolism inhibition

High-performance liquid chromatography of rapamycin

IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1

Radioreceptor Assay for Sirolimus in Patients with Decreased Platelet Counts

Radioreceptor assay for sirolimus

Suchergebnisse filtern